Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;32(11):2901-2914.
doi: 10.1111/jce.15259. Epub 2021 Oct 5.

Cardiac stereotactic body radiation therapy for ventricular tachycardia: Current experience and technical gaps

Chen Wei  1   2 , Pierre C Qian  2 , Michelle Boeck  1   2   3 , Jeremy S Bredfeldt  1   2   3 , Ron Blankstein  2 , Usha B Tedrow  2 , Raymond Mak  3 , Paul C Zei  2
Affiliations
Review

Cardiac stereotactic body radiation therapy for ventricular tachycardia: Current experience and technical gaps

Chen Wei et al. J Cardiovasc Electrophysiol. 2021 Nov.

Abstract

Introduction: Despite advances in drug and catheter ablation therapy, long-term recurrence rates for ventricular tachycardia remain suboptimal. Cardiac stereotactic body radiotherapy (SBRT) is a novel treatment that has demonstrated reduction of arrhythmia episodes and favorable short-term safety profile in treatment-refractory patients. Nevertheless, the current clinical experience is early and limited. Recent studies have highlighted variable duration of treatment effect and substantial recurrence rates several months postradiation. Contributing to these differential outcomes are disparate approaches groups have taken in planning and delivering radiation, owing to both technical and knowledge gaps limiting optimization and standardization of cardiac SBRT.

Methods and findings: In this report, we review the historical basis for cardiac SBRT and existing clinical data. We then elucidate the current technical gaps in cardiac radioablation, incorporating the current clinical experience, and summarize the ongoing and needed efforts to resolve them.

Conclusion: Cardiac SBRT is an emerging therapy that holds promise for the treatment of ventricular tachycardia. Technical gaps remain, to be addressed by ongoing research and growing clincial experience.

Keywords: ablation; cardiac arrhythmias; noninvasive therapy; radiosurgery; radiotherapy; stereotactic body radioablation therapy; ventricular tachycardia.

PubMed Disclaimer

References

REFERENCES

    1. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657-2665.
    1. Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111-121.
    1. Kuck K-H, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet Lond Engl. 2010;375(9708):31-40.
    1. Kumar S, Romero J, Mehta NK, et al. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Heart Rhythm. 2016;13(10):1957-1963.
    1. Kuck K-H, Tilz RR, Deneke T, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol. 2017;10(3):e004422.

LinkOut - more resources